- Home
- ULBI vs RGC Comparison
ULBI vs RGC Comparison
Compare ULBI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULBI
- RGC
- Stock Information
- Founded
- ULBI 1990
- RGC 2014
- Country
- ULBI United States
- RGC Hong Kong
- Employees
- ULBI N/A
- RGC N/A
- Industry
- ULBI Industrial Machinery/Components
- RGC Medicinal Chemicals and Botanical Products
- Sector
- ULBI Miscellaneous
- RGC Health Care
- Exchange
- ULBI Nasdaq
- RGC Nasdaq
- Market Cap
- ULBI 158.1M
- RGC 105.3M
- IPO Year
- ULBI 1992
- RGC 2021
- Fundamental
- Price
- ULBI $7.76
- RGC $4.86
- Analyst Decision
- ULBI Strong Buy
- RGC
- Analyst Count
- ULBI 1
- RGC 0
- Target Price
- ULBI $14.00
- RGC N/A
- AVG Volume (30 Days)
- ULBI 54.3K
- RGC 8.8K
- Earning Date
- ULBI 02-13-2025
- RGC 10-25-2024
- Dividend Yield
- ULBI N/A
- RGC N/A
- EPS Growth
- ULBI 115.20
- RGC N/A
- EPS
- ULBI 0.54
- RGC N/A
- Revenue
- ULBI $165,152,000.00
- RGC N/A
- Revenue This Year
- ULBI $3.26
- RGC N/A
- Revenue Next Year
- ULBI $36.05
- RGC N/A
- P/E Ratio
- ULBI $14.23
- RGC N/A
- Revenue Growth
- ULBI 9.95
- RGC N/A
- 52 Week Low
- ULBI $6.63
- RGC $3.03
- 52 Week High
- ULBI $13.39
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- ULBI 55.36
- RGC 44.96
- Support Level
- ULBI $7.15
- RGC $4.75
- Resistance Level
- ULBI $7.83
- RGC $5.21
- Average True Range (ATR)
- ULBI 0.28
- RGC 0.30
- MACD
- ULBI 0.05
- RGC 0.04
- Stochastic Oscillator
- ULBI 86.05
- RGC 23.87
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.